Skip to main content

Table 1 Patient characteristics

From: Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

  Type 2 diabetes discovery cohort (n = 49) Type 1 diabetes validation cohort (n = 50)
Baseline
 Age (years) 59.0 (10.0) 44.6 (8.9)
 Male sex (number (%)) 39 (80) 30 (60)
 SBP (mmHg) 140.0 (15.4) 150.6 (17.7)
 DBP (mmHg) 81.6 (8.8) 84.7 (10.9)
 HbA1c (%) 8.3 (1.4) 8.9 (1.2)
 HbA1c (mmol/mol) 67.2 (15.3) 73.8 (13.1)
 Cholesterol (mmol/l) 5.3 (1.0) 5.2 (1.0)
 HDL (mmol/l) 1.2 (0.3) 1.6 (0.5)
 GFR (ml/min/1.73 m2) 102.3 (19.2) 86.5 (23.4)
 24-h UAE (mg/24 h) 84 [65, 200] 1211 [598, 2023]
Follow-up
 Change in SBP (mmHg) −6.4 (16.2) −8.7 (14.3)
 Change in DBP (mmHg) −6.0 (8.8) −5.6 (8.6)
 Percent change in UAE (%) −42 % [−69, −8] −43 % [−62, −23]
 >30 % decrease in UAE from baseline [number (%)] 31 (63) 34 (68)
 GFR change after response period (mL/min/1.73 m2/year) Not available −3.8 (3.6)
  1. Data are reported as mean ± standard deviation (SD) or number (percent) or median [25th, 75th percentile]